DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

1.69 -0.03 (-1.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PPHM $1.69 -1.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.72
Previous Close $1.72
Daily Range $1.60 - $1.79
52-Week Range $1.11 - $3.18
Market Cap $298.3M
P/E Ratio -8.36
Dividend (Yield) $0.00 (0.0%)
Volume 3,183,082
Average Daily Volume 6,110,015
Current FY EPS -$0.22

Sector

Healthcare

Industry

Drugs

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

UPDATE: Peregrine Pharma Reports Data on Bavituximab Presented at AACR Validates Immune-Stimulatory

UPDATE: Peregrine Pharma Reports Data on Bavituximab Presented at AACR Validates Immune-Stimulatory Mechanism of Action

Morning Market Movers

Peregrine Pharmaceuticals (PPHM) Shares March Higher, Can It Continue? - Tale of the Tape

Peregrine Pharmaceuticals (PPHM) Shares March Higher, Can It Continue? - Tale of the Tape

Cel-Sci's Multikine - Potential 21st Century Superdrug

Loss Widens at Peregrine, Shares Down - Analyst Blog

Mid Morning Gainers for March 11th, 2014

Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares Drop

Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares Drop

Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales Fall 0.3%

Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales Fall 0.3%

See More PPHM News...

PPHM's Top Competitors

PPHM $1.69 (-1.74%)
Current stock: PPHM
AMGN $115.00 (1.48%)
Current stock: AMGN
GILD $68.17 (2.07%)
Current stock: GILD
BIIB $285.49 (2.14%)
Current stock: BIIB